AU2002210749B2 - Kahalalide F formulation - Google Patents
Kahalalide F formulation Download PDFInfo
- Publication number
- AU2002210749B2 AU2002210749B2 AU2002210749A AU2002210749A AU2002210749B2 AU 2002210749 B2 AU2002210749 B2 AU 2002210749B2 AU 2002210749 A AU2002210749 A AU 2002210749A AU 2002210749 A AU2002210749 A AU 2002210749A AU 2002210749 B2 AU2002210749 B2 AU 2002210749B2
- Authority
- AU
- Australia
- Prior art keywords
- kahalalide
- cancer
- formulation
- infusion
- mix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Carbon And Carbon Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24447100P | 2000-10-31 | 2000-10-31 | |
| US60/244,471 | 2000-10-31 | ||
| US24622900P | 2000-11-06 | 2000-11-06 | |
| US60/246,229 | 2000-11-06 | ||
| US34844901P | 2001-10-19 | 2001-10-19 | |
| US60/348,449 | 2001-10-19 | ||
| PCT/GB2001/004821 WO2002036145A2 (en) | 2000-10-31 | 2001-10-31 | Kahalalide f formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002210749A1 AU2002210749A1 (en) | 2002-07-18 |
| AU2002210749B2 true AU2002210749B2 (en) | 2006-12-21 |
Family
ID=27399760
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002210749A Ceased AU2002210749B2 (en) | 2000-10-31 | 2001-10-31 | Kahalalide F formulation |
| AU1074902A Pending AU1074902A (en) | 2000-10-31 | 2001-10-31 | Kahalalide f |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU1074902A Pending AU1074902A (en) | 2000-10-31 | 2001-10-31 | Kahalalide f |
Country Status (22)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| EP1435990A1 (en) * | 2001-10-19 | 2004-07-14 | Pharma Mar, S.A. | Kahalalide compounds for use in cancer therapy |
| US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
| DE60335292D1 (de) * | 2002-10-18 | 2011-01-20 | Pharma Mar Sau | 4-methylhexanoic kahalalide f verbindung |
| CN101077885A (zh) * | 2002-10-18 | 2007-11-28 | 马尔药品公司 | 新型抗肿瘤化合物 |
| GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
| US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
| DE10329847A1 (de) * | 2003-07-02 | 2005-01-20 | Toximed Gmbh | Pharmazeutischer Wirkstoff gegen Prostatakarzinome |
| GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
| GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
| RS50822B (sr) * | 2004-10-26 | 2010-08-31 | Pharma Mar S.A., Sociedad Unipersonal | Pegilovani lipozomalni doksorubicin u kombinaciji sa ekteinescidinom 743 |
| KR101188691B1 (ko) * | 2004-10-29 | 2012-10-09 | 파르마 마르 에스.에이. | 엑티나시딘 및 디사카라이드를 포함하는 제제 |
| GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
| CN101861159A (zh) * | 2007-10-19 | 2010-10-13 | 马尔药品公司 | 改进的抗肿瘤治疗 |
| EP2252315A1 (en) * | 2008-01-30 | 2010-11-24 | Pharma Mar, S.A. | Improved antitumoral treatments |
| AU2009221120A1 (en) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Improved antitumoral treatments |
| WO2009135939A2 (en) * | 2008-05-09 | 2009-11-12 | Pharma Mar, S.A. | Depsipeptide for use in cancer therapy |
| LT3615544T (lt) | 2017-04-27 | 2023-05-10 | Pharma Mar S.A. | Priešnavikiniai junginiai |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| JP2799483B2 (ja) | 1988-03-09 | 1998-09-17 | 大塚製薬株式会社 | インターロイキン−１β組成物の安定化方法 |
| GB8819607D0 (en) * | 1988-08-17 | 1988-09-21 | Wellcome Found | Novel combination |
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| JP2971680B2 (ja) | 1991-10-02 | 1999-11-08 | 山之内製薬株式会社 | 組織プラスミノーゲン活性化因子含有組成物 |
| JPH0597703A (ja) | 1991-10-04 | 1993-04-20 | Yamanouchi Pharmaceut Co Ltd | 改変型組織プラスミノーゲン活性化因子含有組成物 |
| US5550124A (en) | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
| US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
| GB9302046D0 (en) | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
| US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
| JP3927248B2 (ja) * | 1995-07-11 | 2007-06-06 | 第一製薬株式会社 | Ｈｇｆ凍結乾燥製剤 |
| GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| JPH1014581A (ja) | 1996-07-08 | 1998-01-20 | Morinaga Milk Ind Co Ltd | ウサギ型マクロファージ・コロニー刺激因子及びこれをコードするｄｎａ断片 |
| DE69719265T2 (de) | 1996-09-06 | 2003-12-04 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto | Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält |
| JP4025394B2 (ja) * | 1996-09-06 | 2007-12-19 | 財団法人化学及血清療法研究所 | 組織プラスミノーゲン活性化因子医薬組成物 |
| GB9803448D0 (en) * | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| GB9807639D0 (en) | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| WO2000016794A1 (en) | 1998-09-23 | 2000-03-30 | Marcus Keep | Neuroimmunophilins for selective neuronal radioprotection |
| GB0002952D0 (en) | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
-
2001
- 2001-10-31 US US10/399,571 patent/US7473681B2/en not_active Expired - Fee Related
- 2001-10-31 WO PCT/GB2001/004821 patent/WO2002036145A2/en not_active Ceased
- 2001-10-31 CZ CZ20031211A patent/CZ20031211A3/cs unknown
- 2001-10-31 HK HK03106441.9A patent/HK1054192B/en not_active IP Right Cessation
- 2001-10-31 IL IL15529701A patent/IL155297A0/xx unknown
- 2001-10-31 JP JP2002538956A patent/JP2004512370A/ja active Pending
- 2001-10-31 AU AU2002210749A patent/AU2002210749B2/en not_active Ceased
- 2001-10-31 CN CNA018182712A patent/CN1568192A/zh active Pending
- 2001-10-31 CA CA002425627A patent/CA2425627A1/en not_active Abandoned
- 2001-10-31 DE DE60116359T patent/DE60116359T2/de not_active Expired - Lifetime
- 2001-10-31 MX MXPA03003704A patent/MXPA03003704A/es active IP Right Grant
- 2001-10-31 BR BR0114912-1A patent/BR0114912A/pt active Search and Examination
- 2001-10-31 ES ES01978654T patent/ES2256305T3/es not_active Expired - Lifetime
- 2001-10-31 HU HU0600031A patent/HUP0600031A3/hu unknown
- 2001-10-31 EP EP01978654A patent/EP1330258B1/en not_active Expired - Lifetime
- 2001-10-31 SK SK502-2003A patent/SK286421B6/sk not_active IP Right Cessation
- 2001-10-31 AT AT01978654T patent/ATE314084T1/de active
- 2001-10-31 NZ NZ525243A patent/NZ525243A/en unknown
- 2001-10-31 AU AU1074902A patent/AU1074902A/xx active Pending
- 2001-10-31 KR KR1020037005347A patent/KR100834138B1/ko not_active Expired - Fee Related
- 2001-10-31 DK DK01978654T patent/DK1330258T3/da active
-
2003
- 2003-04-08 IL IL155297A patent/IL155297A/en not_active IP Right Cessation
- 2003-04-25 NO NO20031860A patent/NO331082B1/no not_active IP Right Cessation
-
2006
- 2006-03-24 CY CY20061100415T patent/CY1105009T1/el unknown
-
2009
- 2009-10-23 JP JP2009244772A patent/JP2010047601A/ja active Pending
Non-Patent Citations (1)
| Title |
|---|
| References cited in WO 02/36145 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7473681B2 (en) | Kahalalide F | |
| AU2002210749A1 (en) | Kahalalide F formulation | |
| JP2004512370A5 (cg-RX-API-DMAC7.html) | ||
| US9624187B2 (en) | Oxathiazine derivatives as antibacterial and anticancer agents | |
| JPWO2012111762A1 (ja) | 抗ｃｄ４０抗体の高濃度製剤 | |
| US9814759B2 (en) | Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment | |
| TW201632174A (zh) | 使用晶體工程及茶胺酸溶解之平台藥物遞送系統 | |
| WO2021203467A1 (zh) | 一类脂肽化合物在抗新型冠状病毒中的应用 | |
| JP2020125359A (ja) | ペメトレキセドまたはその薬剤学的に許容可能な塩を含有する安定化された薬学組成物 | |
| WO2013188874A1 (en) | Methods of mitigating side effects of radiation exposure and chemotherapy | |
| US20050054555A1 (en) | Kahalalide compounds for use in cancer therapy | |
| RU2292216C2 (ru) | Кахалалид f | |
| AU2002334203B2 (en) | Kahalalide compounds for use in cancer therapy | |
| AU2002334203A1 (en) | Kahalalide compounds for use in cancer therapy | |
| US20230201168A1 (en) | New therapy for the treatment of tumors | |
| PL203676B1 (pl) | Liofilizowany preparat kahalalidu F, zestaw, odtworzony roztwór i zastosowanie | |
| EP3986862A1 (en) | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | |
| US20250041234A1 (en) | Use of thermostable exoshells for lyophilization of labile substrates | |
| EP4087532A1 (en) | Peptide-containing composition for use for treating neoplastic lesions | |
| KR20210101193A (ko) | 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제 | |
| Mucke | Patent Highlights June–July 2015 | |
| CN105078993B (zh) | 一种吲唑类化合物组合物及其制备方法和应用 | |
| Kumar | Design, Synthesis and Biological evaluation of Verapamil analogues, Reversed Isoniazids and Hybrid efflux pump inhibitors against Mycobacterium tuberculosis | |
| JP2007191417A (ja) | 医薬用の組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |